Mediclinic International PLC (LON:MDC) had its price objective cut by stock analysts at Macquarie from GBX 970 ($12.12) to GBX 830 ($10.37) in a research note issued on Wednesday. The firm presently has a “neutral” rating on the stock. Macquarie’s price target indicates a potential upside of 13.62% from the company’s current price. A number […]